Researchers at Brown’s Carney Institute for Brain Science identified a pair of neurons that integrate sweet and bitter signals to decide whether something is safe to eat.

The findings could help clinicians use neuropsychiatric symptoms to prepare patients and families for a type of dementia previously only diagnosed via autopsy.

Implantable device research from the BrainGate clinical trial enables communication through rapid typing for a patient with ALS and a patient with a spinal cord injury.